• Home
  • About Us
  • Contact
  • Subscribe
  • Your Account
  • Login
No Result
View All Result
Tuesday, June 6, 2023
Alternatives Watch
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
No Result
View All Result
Alternatives Watch
No Result
View All Result

Blackstone’s BioMed Realty makes big lab space play in Cambridge, UK

Sergio BarretobySergio Barreto
September 22, 2021
in Manager News, Open Access, Real Estate/Infrastructure
Blackstone's BioMed Realty makes big lad space play in Cambridge, UK

A Granta Park lab (provided)

ShareTweetShareSendSend

Blackstone portfolio company BioMed Realty is investing an estimated £850 million ($1.16 billion) to purchase two properties in Cambridge, UK, and develop about 800,000 square feet of lab space.

Biomed is purchasing the 15-acre Cambridge International Technology Park from Abstract Securities, as well as a 27-acre land plot at Granta Park from The Welding Institute. The proposed new sites are still subject to planning consent, and if approved would double BioMed’s current life sciences real estate in Cambridge and support the creation of up to 2,700 new jobs.

BioMed entered the Cambridge market in 2012 and has since become the area’s largest private owner of life science space. The firm’s existing holdings at Babraham Research Campus and Granta Park itself already provide incubator space, scale-up space for growth and headquarter space to 22 companies, including major drugmakers such as Pfizer, Gilead and AstraZeneca.

“This investment is hugely welcome news for Cambridge and the UK as a whole.”

Prime minister boris johnson

The life sciences sector is a crucial part of the UK economy, supporting 250,000 jobs and contributing over £80 billion to GDP annually. Cambridge, home to the world’s fourth-oldest surviving university and the birthplace of cutting-edge technologies including artificial intelligence and stem cell research, has more labs than anywhere else in the UK — but according to Biomed, latest survey data shows all of the area’s lab space is currently under offer, potentially closing doors to startups as well as established companies in this dynamic market.

“This investment is hugely welcome news for Cambridge and the UK as a whole,” said Prime Minister Boris Johnson. “The jobs created by this investment are exactly the kind we want to see more of in the UK – high-skilled and future-facing, reflecting what the UK does best.”

Bill Kane, East Coast & UK Market president at BioMed Realty, said the planned new developments “will provide much needed life science space for existing and new companies, further advancing Cambridge as a global home for research while supporting the local economy.”

James Seppala, head of Real Estate in Europe at Blackstone, added, “Life sciences remains one of Blackstone’s highest conviction investment themes. Together with BioMed Realty, we are committed to growing this area of investment for the long-term and providing the high-quality space that is needed to bring life-saving products and therapies to market and ensure the UK’s future success as a global leader in vaccine and drug development.”

Tags: BioMed RealtyBlackstoneLife SciencesU.K.
ShareTweetShareSendSend
Previous Post

Phocas Q4 REITs outlook details COVID ongoing impact

Next Post

University of Michigan invests $340m in venture capital firms

Related Posts

ICG Real Estate adds European platform
Real Estate/Infrastructure

ICG Real Estate adds European platform

People moves in the alternative investments industry
Consultants

People moves for week of June 2

Tikehau partners for European real estate credit platform
Manager News

Tikehau partners for European real estate credit platform

IMRF approves $315m in new commitments
Pensions

IMRF approves $315m in new commitments

Rhode Island adds to private assets
Consultants

Rhode Island adds to private assets

Next Post
University of Michigan invests $340m in venture capital firms

University of Michigan invests $340m in venture capital firms

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Private equity mega-deals shine

Private equity mega-deals shine

HPS attracts $10bn for senior lending

HPS attracts $10bn for senior lending

Music Beats Cancer supports early stage biotechs, plans NYC benefit concert

Music Beats Cancer supports early stage biotechs, plans NYC benefit concert

CDPQ hires in NYC, taps brakes on China investments

CDPQ hires in NYC, taps brakes on China investments

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Investor News
  • Private Equity
  • Private Credit
  • Hedge Funds
  • Real Estate/Infrastructure
  • Subscribe
  • Your Membership
  • Terms of Service
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

This Website Uses Cookies
We use cookies on our website to provide necessary functions. By clicking “Accept”, you consent to the use of all strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo